Summary:
- This article discusses a new study that has found a link between the use of certain antidepressant medications and an increased risk of developing type 2 diabetes.
- The study analyzed data from over 200,000 adults and found that those who were prescribed selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) had a higher risk of developing type 2 diabetes compared to those who did not take these medications.
- The researchers suggest that the findings highlight the importance of closely monitoring the metabolic health of individuals taking these types of antidepressants and emphasize the need for further research to understand the underlying mechanisms behind this association.